In The News Posted December 8, 2021 Share Posted December 8, 2021 - Biovaxys anuncia una importante colaboración en investigación con la Universidad Estatal de Ohio para desarrollar una vacuna contra el sarbecovirus ampliamente reactiva VANCOUVER, BC, 8 de diciembre de 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now